102940 — Kolon Life Science Cashflow Statement
0.000.00%
Last trade - 00:00- KR₩331bn
- KR₩445bn
- KR₩161bn
Annual cashflow statement for Kolon Life Science, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -43,195 | -1,375 | 2,133 | -30,726 | -93,086 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 16,327 | 8,346 | 4,939 | 12,620 | 76,421 |
| Unusual Items | |||||
| Purchased R&D | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 6,532 | -34,458 | -37,393 | -15,590 | -6,296 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -7,307 | -16,187 | -20,854 | -24,866 | -14,085 |
| Capital Expenditures | -2,743 | -4,413 | -6,308 | -10,237 | -8,727 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 21,780 | 2,158 | 371 | 3,211 | 2,345 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Sale of Intangible Assets | |||||
| Change in Net Intangibles | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 19,037 | -2,255 | -5,937 | -7,026 | -6,382 |
| Financing Cash Flow Items | — | — | — | — | -14,551 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -2,379 | 30,949 | 5,458 | 32,889 | 24,779 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 9,087 | 12,799 | -21,429 | 1,190 | 4,937 |